Craig Hallum Issues Pessimistic Forecast for MaxCyte (NASDAQ:MXCT) Stock Price
MaxCyte (NASDAQ:MXCT – Get Free Report) had its target price lowered by stock analysts at Craig Hallum from $7.00 to $5.00 in a research report issued on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Other analysts have also recently issued research reports about the stock. Wall Street Zen cut shares [...]